| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6123397 | Journal of Infection | 2010 | 6 Pages |
Abstract
Anti-EPO are an independent risk factor for anemia in HIV-1-infected patients. HAART seems to reduce both anti-EPO and anemia prevalence.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Aristotelis Tsiakalos, Theodore Kordossis, Panayiotis D. Ziakas, Athanasios N. Kontos, Despina Kyriaki, Nikolaos V. Sipsas,